Natco Pharma Q1 profit slumps 57% on weak Lenalidomide sales

Natco Pharma is a company in Mumbai, India, that makes medicines.

It makes many medicines, including a cancer-treating drug called lenalidomide.

The company shared its money results for the first three months ending June 2026.

Its profit fell by 57 percent compared with the same time last year.

This happened because sales of lenalidomide were much lower.

The company's total revenue also dropped sharply, mostly from medicines sold abroad.

However, some parts of the business grew, such as medicines sold inside India.

The company also spent less money, which helped a little.